参考文献/References:
[1] Adriaens I, Smitz J, Jacquet P. The current knowledge on radiosensitivity of ovarian follicle development stages[J]. Hum Reprod Update, 2009, 15 (3):359-377. DOI:10.1093/humupd/dmn063.
[2] Said RS, El-Demerdash E, Nada AS, et al. Resveratrol inhibits inflammatory signaling implicated in ionizing radiation-induced premature ovarian failure through antagonistic crosstalk between silencing information regulator 1 (SIRT1) and poly (ADP-ribose) polymerase 1 (PARP-1)[J]. Biochem Pharmacol, 2016, 103:140-150. DOI:10.1016/j.bcp.2016.01.019.
[3] 谭燕, 颜高姝, 刁鹏, 等. 促性腺激素释放激素激动剂对辐射所致大鼠卵巢功能损伤的防护作用研究[J]. 国际放射医学核医学杂志, 2017, 41 (5):314-320. DOI:10.3760/cma.j.issn.1673-4114. 2017.05.002. Tan Y, Yan GS, Diao P, et al. Protective effect of gonadotropin-releasing hormone agonist on ovarian functional impairment caused by radiation in rats[J]. Int J Radiat Med Nucl Med, 2017, 41 (5):314-320.
[4] Del MastroL. Temporary ovarian suppression with goserelin and ovarian function protection in patients with breast cancer undergoing chemotherapy[J]. J Clin Oncol, 2011, 29 (24):3339-3340. DOI:10.1200/JCO.2011.36.9942.
[5] Guenther V, Alkatout I, Junkers W, et al. Fertility Preservation in Female Patients with Breast Cancer-a Current Dverview[J]. Geburtshife FrauenheilkD, 2017, 77 (10):1088-1094. DOI:10.1055/s-0043-119543.
[6] Moore HC, Unger JM, Phillips KA, et al. Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy[J]. N Engl J Med, 2015, 372 (10):923-932. DOI:10.1056/NEJMoa1413204.
[7] Baines E. GnRH antagonist protects ovarian function[J]. Lancet Oncol, 2007, 8 (8):675.
[8] Lobo RA. Potential options for preservation of fertility in women[J]. N Engl J Med, 2005, 353 (1):64-73. DOI:10.1056/NEJMra043475.
[9] Rodriguez-Wallberg K, Turan V, Munster P, et al. Can ovarian suppression with gonadotropin-releasing hormone analogs (GnRHa) preserve fertility in cancer patients?[J]. Ann Oncol, 2016, 27 (2):357. DOI:10.1093/annonc/mdv554.
[10] Lambalk CB, Banga FR, Huirne JA, et al. GnRH antagonist versus long agonist protocols in IVF:a systematic review and meta-analysis accounting for patient type[J]. Hum Reprod Update, 2017, 23 (5):560-579. DOI:10.1093/humupd/dmx017.
[11] Demeestere I, Brice P, Peccatori FA, et al. Gonadotropin-releasing hormone agonist for the prevention of chemotherapy-induced ovarian failure in patients with lymphoma:1-year follow-up of a prospective randomized trial[J]. J ClinOncol, 2013, 31 (7):903-909. DOI:10.1200/JCO.2012.42.8185.
[12] Song G, Chen Y, Liang C, et al. Catalase-Loaded TaOxNanoshells as Bio-Nanoreactors Combining High-Z Element and Enzyme Delivery for Enhancing Radiotherapy[J]. Adv Mater, 2016, 28 (33):7143-7148. DOI:10.1002/adma.201602111.
相似文献/References:
[1]李景涛,邓垒,张文珏,等.广泛期小细胞肺癌胸部IMRT后发生放射性肺炎的危险因素分析[J].国际放射医学核医学杂志,2016,40(2):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
Li Jingtao,Deng Lei,Zhang Wenjue,et al.Risk factor analysis for predicting radiation pneumonitis in extensive stage small cell lung cancer patients receiving IMRT thoracic radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):100.[doi:10.3760/cma.j.issn.1673-4114.2016.02.003]
[2]赵德云,李百龙.植物提取物防治放射性肺损伤的现状与展望[J].国际放射医学核医学杂志,2016,40(3):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
Zhao Deyun,Li Bailong.Protective and therapeutic effects of plant extracts on radiation-induced lung injury:present status and future prospects[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):208.[doi:10.3760/cma.j.issn.1673-4114.2016.03.010]
[3]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[4]邓大平,卢峰,孙洪强,等.颅脑肿瘤放射治疗时射野外器官吸收剂量体模法测量与分析[J].国际放射医学核医学杂志,2016,40(4):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
Deng Daping,Lu Feng,Sun Hongqiang,et al.Test and analysis of out-of-field organ dose in intracranial tumor radiotherapy using phantom[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):272.[doi:10.3760/cma.j.issn.1673-4114.2016.04.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]段永璇,邹晓艳,段秀梅,等.数据解析在肿瘤放射治疗中的应用[J].国际放射医学核医学杂志,2015,39(6):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
Duan Yongxuan,Zou Xiaoyan,Duan Xiumei,et al.Data analysis in the field of tumor radiation therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):505.[doi:10.3760/cma.j.issn.1673-4114.2015.06.015]
[8]贾立立,孟粹达,刘晓冬,等.头颈部肿瘤放疗中转化医学相关机制的研究进展[J].国际放射医学核医学杂志,2015,39(3):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
Jia Lili,Meng Cuida,Liu Xiaodong,et al.Development in translational medicine-related mechanisms of radiotherapy for head and neck cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):247.[doi:10.3760/cma.j.issn.1673-4114.2015.03.013]
[9]曹婉婷,李浣洋,陈雪英,等.正常组织在放射治疗中并发的迟发性损伤[J].国际放射医学核医学杂志,2015,39(3):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
Cao Wanting,Li Huanyang,Chen Xueying,et al.Late effects of radiotherapy on normal tissue[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):260.[doi:10.3760/cma.j.issn.1673-4114.2015.03.016]
[10]杜芳芳,郭阳,姜炜.脑转移瘤的放射治疗进展[J].国际放射医学核医学杂志,2015,39(4):328.[doi:10.3760/cma.j.issn.1673-4114.2015.04.012]
Du Fangfang,Guo Yang,Jiang Wei.Advances in radiotherapy of brain metastases[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(5):328.[doi:10.3760/cma.j.issn.1673-4114.2015.04.012]
[11]刘佳,高刚,朴春南,等.调节肿瘤放射敏感性的miRNAs研究进展[J].国际放射医学核医学杂志,2016,40(2):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
Liu Jia,Gao Gang,Piao Chunnan,et al.Progress of microRNAs in regulating tumor radiation sensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):159.[doi:10.3760/cma.j.issn.1673-4114.2016.02.015]
[12]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(5):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[13]殷丽娜,张旭霞,张俊香,等.Wnt/β-catenin信号通路——乳腺癌的潜在治疗靶点[J].国际放射医学核医学杂志,2014,38(4):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
Yin Lina,Zhang Xuxia,Zhang Junxiang,et al.The Wnt/β-catenin signaling pathway-a potential therapeutic target of breast cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(5):252.[doi:10.3760/cma.j.issn.1673-4114.2014.04.011]
[14]翟红彦,苏成海.基因治疗联合放射治疗恶性肿瘤的分子机制[J].国际放射医学核医学杂志,2009,33(2):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
ZHAI Hong-yan,SU Cheng-hai.Molecular mechanism of genetherapy combined radiotherapy for malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2009,33(5):113.[doi:10.3760/cma.j.issn.1673-4114.2009.02.015]
[15]谭燕,颜高姝,刁鹏,等.促性腺激素释放激素激动剂对辐射所致大鼠卵巢功能损伤的防护作用研究[J].国际放射医学核医学杂志,2017,41(5):314.[doi:10.3760/cma.j.issn.1673-4114.2017.05.002]
Tan Yan,Yan Gaoshu,Diao Peng,et al.Protective effect of gonadotropin-releasing hormone agonist on ovarian functional impairment caused by radiation in rats[J].International Journal of Radiation Medicine and Nuclear Medicine,2017,41(5):314.[doi:10.3760/cma.j.issn.1673-4114.2017.05.002]